The global Cancer
Registry Software Market size
is expected to reach USD 103.5 million by 2026, according to a new report by
Grand View Research, Inc., exhibiting a CAGR of 10.5%. Growing incidence of
cancer is expected to aid growth over the forecast period. Currently, cancer is
the second leading cause of death globally, and according to WHO, around 70% of
the deaths occur in low- and middle-income countries.
Moreover, rising adoption of
Electronic Health Records (EHRs) in developed countries and increasing need for
cancer registries for post-marketing surveillance are among the factors further
anticipated to boost the demand for cancer registry software in the coming
years. Market players are constantly involved in software updation in an
attempt to minimize security risks and provide efficient software, thereby
increasing market visibility and adoption. For instance, in April 2018, Elekta
invested in PalabraApps LLC to improve its MOSAIQ Oncology Information System
software.
Increasing number of clinical
trials being conducted by major pharmaceutical and biotechnological companies
is expected to drive the market over the forecast period. Cancer registry data
helps in tracking patients for clinical trials. Moreover, the affected
locations for any specific type of cancer can be identified by using this
software. Major pharmaceutical companies are increasingly preferring cancer
registry software owing to less requirement of internal staff, increased
cost-effectiveness, and efficient management of resources, which is further
widening the scope for growth.
Browse Details of Report @
https://www.grandviewresearch.com/industry-analysis/cancer-registry-software-market
https://www.grandviewresearch.com/industry-analysis/cancer-registry-software-market
Further key
findings from the report suggest:
- Increasing cancer burden in developing and developed
countries is expected to create growth opportunities in the cancer
registry software market
- Standalone segment accounted for the largest revenue
share in 2018, as it allows multiple system usage and provides other
advantages such as automatic upgrade and easy-to-use tools
- On basis of deployment model, on-premise segment held
the largest share due to high data security and low risk of data breach
- On the basis of component, commercial database held the
largest revenue share due to better compliance features than public
database
- Government & third-party organizations accounted for
the largest revenue owing to increasing adoption of this software by
government agencies for east data tracking
- North America held the largest revenue share as of 2018
due to supportive government initiatives and presence of key industry
players
- Asia Pacific is anticipated to witness lucrative growth
due to increasing government initiatives and presence of untapped
opportunities
- Some of the market key players are Elekta, C/NET
Solutions, Electronic Registry Systems, Inc., Onco, Inc., McKesson
Corporation, and Rocky Mountain.
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment